Immix Biopharma Inc

NAS:IMMXHealthcareCBOEFTSE:MRUTNASDAQ:NQUSSG

$8.07−3.35%LiveIn session · ≈ AED 29.64 · Market cap $669.03M · Next earnings Fri 6 Nov

IMMX · Ratios · TradingHolo

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Return on equity	24.3%	−135.5%	−62.5%	−94.0%	−163.1%	−31.4%	−31.4%	+0.0 pts
Return on assets	−212.7%	−134.0%	−55.2%	−77.4%	−94.2%	−28.1%	−28.1%	+0.0 pts
Return on capital employed	9.6%	−7.5%	−60.3%	−99.6%	−159.0%	−28.7%	—	—
Debt / equity	−0.9×	0.0×	0.0×	0.0×	0.1×	0.0×	0.0×	+0.0%
Debt / assets	759.8%	0.3%	0.0%	0.0%	4.7%	1.0%	—	—
Interest coverage	−4.5×	−7.5×	−16,537.1×	0.0×	0.0×	0.0×	—	—
Current ratio	0.1×	90.0×	11.7×	5.3×	2.3×	10.0×	10.0×	+0.0%
Quick ratio	0.1×	90.0×	11.7×	5.3×	2.3×	10.0×	—	—
Cash ratio	0.1×	87.3×	10.6×	4.7×	2.0×	9.3×	9.3×	+0.0%
Asset turnover	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	—	—
Receivables turnover	0.0×	0.0×	0.0×	0.0×	0.0×	—	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—

Margins, returns, leverage and liquidityUpdated 31 Dec 2025 ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.